| Joi Bythwood, | |
|
5785 Hammond Dr, Norcross, GA 30071-3407 | |
| (404) 484-4005 | |
| Not Available |
| Full Name | Joi Bythwood |
|---|---|
| Gender | Female |
| Speciality | Counselor - Mental Health |
| Location | 5785 Hammond Dr, Norcross, Georgia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134673197 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Joi Bythwood, 5785 Hammond Dr, Norcross, GA 30071-3407 Ph: (404) 484-4005 | Joi Bythwood, 5785 Hammond Dr, Norcross, GA 30071-3407 Ph: (404) 484-4005 |
News Archive
In this post in USAID's "IMPACTblog," Anita Malley, internal displacement and protection adviser at the Office of U.S. Foreign Disaster Assistance, examines the importance of addressing sexual violence in conflicts and disasters, recapping a trip she took to Cote d'Ivoire with her colleagues in June.
College-age kids who don't consume at least three servings of dairy daily are three times more likely to develop metabolic syndrome than those who do, said a new University of Illinois study.
Nature interviews Amy Patterson, director of the National Institutes of Health (NIH) Office of Science Policy, which administers the National Science Advisory Board for Biosecurity (NSABB), about the board's decision in December to advise against full publication of "two papers on avian flu (H5N1) that could pose a biosecurity risk if published in their entirety."
Cornerstone Therapeutics Inc., a specialty pharmaceutical company focused on acquiring, developing and commercializing significant products primarily for the respiratory and related markets, today reported that it had received a Warning Letter from the Food and Drug Administration ("FDA") alleging that its Deconsal CT chewable tablets (Phenylephrine HCl 10 mg, Pyrilamine Maleate 16 mg) and Deconsal DM chewable tablets (Phenylephrine HCl 10 mg, Pyrilamine Maleate 16 mg, Dextromothorphan HBr 15 mg) are new drugs lacking an approved application and as such should not be introduced into interstate commerce.
› Verified 2 days ago
Dr. Reginald B. Riley, PH.D. Counselor Medicare: Not Enrolled in Medicare Practice Location: 8000 Miller Ct E, Norcross, GA 30071 Phone: 770-734-8091 Fax: 770-734-8094 | |
Dr. Anthony S Lewis, PHD Counselor Medicare: Not Enrolled in Medicare Practice Location: 5712 Pine Oak Dr, Norcross, GA 30092 Phone: 770-696-1549 | |
Tequila Olivia Banks, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 8303 Dunleaf Arc Way Nw, Norcross, GA 30093 Phone: 470-658-8156 | |
Mercianna R Oliver, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 1780 Graves Rd Apt 514, Norcross, GA 30093 Phone: 404-493-3803 | |
Lan Chen, Counselor Medicare: Not Enrolled in Medicare Practice Location: 3200 Pointe Pkwy, Suite 400, Peachtree Corners, Norcross, GA 30092 Phone: 678-259-9298 | |
Kenanesha Owens, Counselor Medicare: Not Enrolled in Medicare Practice Location: 3040 Holcolmb Bridge Rd Suite J2, Norcross, GA 30071 Phone: 770-696-9231 | |
Diana L Woodruff, PHD Counselor Medicare: Not Enrolled in Medicare Practice Location: 4530 South Berkeley Lake Rd, Suite B, Norcross, GA 30071 Phone: 770-446-5642 Fax: 770-446-5643 |